Biomarin Pharmaceutical Inc. - Registered Shares
NASDAQ:BMRN 1:34:00 PM EDT
| Market Cap (Intraday) | 14.87B |
| Current PE | 377.80 |
| Forward PE | 116.76 |
| 2yr Forward PE | 37.1 |
| 10-Day MA | $78.66 |
| 50-Day MA | $80.17 |
| 200-Day MA | $81.69 |
Biomarin Pharmaceutical Inc. - Registered Shares Stock, NASDAQ:BMRN
770 Lindaro Street, San Rafael, California 94901
United States of America
Phone: +1.415.506.6700
Number of Employees: 3045
Description
BioMarin Pharmaceutical, Inc. engages in the development and commercialization of therapies for people with serious and life-threatening rare diseases and medical conditions. Its pipeline products include Valoctocogene roxaparvovec, Vosoritide, and BMN 307. The company was founded by John C. Klock, Christopher M. Starr and Grant W. Denison on March 21, 1997, and is headquartered in San Rafael, CA.